16 completed, 9 unknown, 8 recruiting, 3 not yet recruiting. 11 Not applicable, 6 Phase 2, 3 Phase 1, 3 Phase 3, 3 Phase 4.
Follow Esophagogastroduodenoscopy: new trials by email Literature Review of Esophagogastroduodenoscopy trials Research Report on Esophagogastroduodenoscopy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Study To Assess The Outcomes Of Nitrous Oxide Cryoablation For Treatment Of Duodenal Adenomas In Patients With Hereditary Conditions Such As FAP, HNPCC Esophagogastroduodenoscopy - Prospective Study , Questionaires, Outcomes | Not applicable | Not yet recruiting | M.D. Anderson Cancer Center | 20 | 2027-03-03 | 2026-10-05 |
| Trans-nasal Endoscopy for Bariatric Patients Transnasal Endoscopy, Esophagogastroduodenoscopy - Obesity, Obesity, Morbid | Not applicable | Recruiting | Christopher C. Thompson, MD, MSc | 100 | 2026-04-20 | 2026-06-25 |
| An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis Biopsy Procedure, Biospecimen Collection, EP2/EP4 Antagonist TPST-1495 - Colorectal Carcinoma, Familial Adenomatous Polyposis | Phase 2 | Recruiting | National Cancer Institute (NCI) | 38 | 2026-03-31 | 2026-09-14 |
| Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores Esophagogastroduodenoscopy - Gastric Retention | Not yet recruiting | Fudan University | 418 | 2025-09-15 | 2025-09-03 | |
| Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention Esophagogastroduodenoscopy - Gastric Retention | Not yet recruiting | Fudan University | 460 | 2025-09-15 | 2025-09-05 | |
| Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer Biopsy, Biospecimen Collection, Breath Test - Gastric Carcinoma | Not applicable | Recruiting | City of Hope Medical Center | 240 | 2024-06-27 | 2026-03-13 |
| Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy Esophagogastroduodenoscopy, Endoscopic biopsy sampling - Gastritis H Pylori, Gastritis Chronic | Not applicable | Completed | Sisli Hamidiye Etfal Training and Research Hospital | 671 | 2024-02-13 | 2024-02-23 |
| Obeticholic Acid for Prevention in Barrett's Esophagus Biospecimen Collection, Esophageal Biopsy, Esophagogastroduodenoscopy - Barrett Esophagus, Esophageal Adenocarcinoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 30 | 2024-01-03 | 2026-08-11 |
| Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma Biospecimen Collection, Computed Tomography, Endoscopic Ultrasound - Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | Recruiting | Mayo Clinic | 99 | 2023-11-21 | 2026-10-01 |
| Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma Zanubrutinib, Rituximab, Patient Observation - Mantle Cell Lymphoma | Phase 3 | Recruiting | Alliance for Clinical Trials in Oncology | 421 | 2023-10-20 | 2026-10-02 |
| Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices wired magnetic assisted capsule endoscopy, esophagogastroduodenoscopy - Esophageal Varices | Not applicable | Completed | National Taiwan University Hospital | 50 | 2023-09-05 | 2026-01-23 |
| GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy Esophagogastroduodenoscopy - Gastric Content Aspiration | Completed | Medical University of South Carolina | 260 | 2023-08-21 | 2024-09-19 | |
| Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients esophagogastroduodenoscopy - Chronic Kidney Diseases | Not applicable | Unknown | Sohag University | 100 | 2023-07-01 | 2023-07-03 |
| 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) APT-1011, Placebo oral tablet, Esophagogastroduodenoscopy - Eosinophilic Esophagitis | Phase 3 | Completed | Ellodi Pharmaceuticals, LP | 218 | 2022-12-29 | 2025-08-13 |
| GCC Agonist Signal in the Small Intestine Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy - Barrett Esophagus, Gastroesophageal Reflux Disease | Phase 1 | Completed | University of Wisconsin, Madison | 43 | 2022-11-30 | 2026-04-07 |
| Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus Cytosponge, Transnasal Endoscopy (TNE), Esophagogastroduodenoscopy - Barrett Esophagus, GERD | Not applicable | Completed | University of North Carolina, Chapel Hill | 24 | 2020-08-11 | 2023-05-08 |
| Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC EsoGuard (lab assay), Esophagogastroduodenoscopy - Barrett Esophagus, Esophageal Adenocarcinoma | Not applicable | Active not recruiting | Lucid Diagnostics, Inc. | 784 | 2020-06-18 | 2026-09-21 |
| Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study Esophagogastroduodenoscopy - Helicobacter Pylori, Atrophic Gastritis | Recruiting | Chinese University of Hong Kong | 260 | 2020-05-15 | 2026-09-22 | |
| Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) APT-1011, Placebo oral tablet, Esophagogastroduodenoscopy - Eosinophilic Esophagitis | Phase 3 | Completed | Ellodi Pharmaceuticals, LP | 143 | 2020-01-30 | 2023-06-12 |
| GastrOesophageal Varices After Sustained Virological Response Liver elastography, Splenic elastography, Gastrointestinal endoscopy - Liver Diseases, Hepatitis C | Unknown | Oswaldo Cruz Foundation | 322 | 2019-11-26 | 2019-12-09 |
Showing 20 of 37. Sign in to see all of them.
Barrett Esophagus (6) · Gastroesophageal Reflux (6) · Adenocarcinoma Of Esophagus (4) · Digestive System Diseases (3) · Eosinophilic Esophagitis (3) · Esophagitis (3) · Gastrointestinal Diseases (3) · Adenomatous Polyposis Coli (2) · Eosinophilia (2) · Esophageal Diseases (2) · Gastroenteritis (2) · Hematologic Diseases (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Hypertension, Portal (2)
Mayo Clinic (3) · Nanfang Hospital, Southern Medical University (3) · Ellodi Pharmaceuticals, LP (2) · Fudan University (2) · National Cancer Institute (NCI) (2) · Alliance for Clinical Trials in Oncology (1) · Assaf-Harofeh Medical Center (1) · Case Comprehensive Cancer Center (1) · Chinese University of Hong Kong (1) · Christopher C. Thompson, MD, MSc (1) · City of Hope Medical Center (1) · Copenhagen University Hospital, Hvidovre (1) · Instituto Ecuatoriano de Enfermedades Digestivas (1) · Kashgar 1st People's Hospital (1) · Lucid Diagnostics, Inc. (1)
United States (22) · China (6) · Turkey (Türkiye) (3) · Thailand (2) · Australia (1) · Brazil (1) · Canada (1) · Denmark (1) · Ecuador (1) · Egypt (1) · Germany (1) · Hong Kong (1) · Indonesia (1) · Israel (1) · Japan (1)
Danian Ji, M.D. (2) · Evan Dellon, MD, MPH (2) · Xiaolong Qi, MD (2) · Amitabh Chak (1) · Burak Dincer, M.D. (1) · Christopher C. Thompson, MD, MSc (1) · Christopher L. Hallemeier, MD (1) · David S Weinberg (1) · Efrat Broide, MD (1) · Gerald Gleich, MD (1) · Hongwei Zhou, PhD (1) · Hugo Perazzo, PhD (1) · Jason A. Dominitz, MD (1) · Jens Siveke, Prof. Dr. (1) · Jiahong Dong, MD (1)
PMID 33074566, PMID 34327406, PMID 38957011
P30CA014520 (2), UG1CA242635 (2), P30CA033572 (1), P30CA043703 (1), P30CA046592 (1), P30CA069533 (1), P50CA150964 (1), R01CA274985 (1), R01CA294704 (1), U54CA163060 (1), UG1CA242596 (1), UG1CA242632 (1)